Amoy Diagnostics Co., Ltd.

¥19.08As of Sun 8 Nov 2026, 12:00 UTC
SZSE:300685Healthcare
Country China
PE (Fwd) •••
TSR 9Y CAGR 0.88%
Div yield 2.36%
ROE 17.63%
Diagnostics & Research
Beta (5Y) 0.36
PE TTM 22.16
TSR TTM (14.55%)
Mkt cap ¥7.269B
ROIC 42.09%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥18
(4.30%)
(69.09%)
Hold 10|9|1|1|3
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.26
0.29
0.31
0.30
7.33%
20.28%
33.00%
19.17%
Revenue¥M
553.2
575.3
573.2
589.2
7.73%
9.97%
10.24%
12.42%
Peers (US$1.090B)
Cap (US$)
PE
1.125B
30.08x
1.094B
—
Capital
TTM
5Y
10Y
Leveragex
1.045
(0.044)
(0.033)
EBIT/Intx
0.936
0.212
0.189
Own earn%
(16.37)
134.17
142.78
Sh yield%
25.79
28.08
26.07
Owners
Insiders/Inst%
8.75
73.63
Short interest%
5.54
SBC / revenue%
2.16
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
11
Op margin range%
8–17
$1 testx
1.2
Incr. ROIC%
7